Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid and is used to dissolve gallstones that are rich in cholesterol. It is also used to improve the flow of bile in primary biliary cirrhosis. UDCA solubilizes cholesterol gallstones and improves the liver function in case of cholestatic diseases. UDCA can be obtained from cholic acid, which is the most abundant and least expensive bile acid available.
Market Dynamics
Increasing incidence of gallstones and cystic fibrosis is expected to propel demand for UDCA, thereby driving the ursodeoxycholic acid market growth. According to a study published in the journal Gastroenterology, 2009, cholelithiasis, the presence of gallstones in the gallbladder, is estimated to occur in 10 - 15% of the adult population in the U.S. Although, gallstones can occur at any age, it is rare before the age of 30. A progressive increase in risk of cholelithiasis is observed with age and in patients over 50, the prevalence ranges is between 25-30%.
Moreover, prevalence of gallstones is two to three times higher in women than in men. According to the American College of Gastroenterology 2018 report, gallstones occur in around 20% of women by the age of 60. Moreover, women between the age of 20 and 60 years are three times more likely to develop gallstones than men.
Furthermore, increasing research studies conducted over the applications of UCDA in other disease indications is expected to fuel growth of the global ursodeoxycholic acid market. According to the University of Sheffield August 2018 study, UDCA improves mitochondrial dysfunction, which is known to be a causative factor for both sporadic and familial Alzheimer's disease. However, side effects associated with the use of UDCA including diarrhoea, indigestion, headache, nausea, vomiting, unusual bleeding or bruising are expected to confine growth of the market during the forecast period.
Key features of the study:
This report provides in-depth analysis of the global ursodeoxycholic acid market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global ursodeoxycholic acid market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Abil Chempharma, Arcelor Chemicals, Biotavia Labs, Daewoong Chemical, Dipharma Francis, Erregierre, Grindeks, ICE, Mitsubishi Tanabe, Pharma Zell, Suzhou Tianlu, and Zhangshanbelling
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global ursodeoxycholic acid market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for ursodeoxycholic acid market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Ursodeoxycholic Acid Market, By Dosage Form:
Liquid
Solid
Global Ursodeoxycholic Acid Market, By Mode of Extraction:
Synthetic
Biological
Global Ursodeoxycholic Acid Market, By Application:
Gallstones
Cystic Fibrosis
Liver Cirrhosis
Others
Global Ursodeoxycholic Acid Market, By Region:
North America
By Country:
U.S.
Canada
By Dosage Form:
Solid
Liquid
By Mode of Extraction:
Synthetic
Liquid
By Application:
Gallstones
Cystic Fibrosis
Liver Cirrhosis
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Dosage Form:
Solid
Liquid
By Mode of Extraction:
Synthetic
Liquid
By Application:
Gallstones
Cystic Fibrosis
Liver Cirrhosis
Others
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Dosage Form:
Solid
Liquid
By Mode of Extraction:
Synthetic
Liquid
By Application:
Gallstones
Cystic Fibrosis
Liver Cirrhosis
Others
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Dosage Form:
Solid
Liquid
By Mode of Extraction:
Synthetic
Liquid
By Application:
Gallstones
Cystic Fibrosis
Liver Cirrhosis
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Dosage Form:
Solid
Liquid
By Mode of Extraction:
Synthetic
Liquid
By Application:
Gallstones
Cystic Fibrosis
Liver Cirrhosis
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Dosage Form:
Solid
Liquid
By Mode of Extraction:
Synthetic
Liquid
By Application:
Gallstones
Cystic Fibrosis
Liver Cirrhosis
Others
Company Profiles
Abil Chempharma*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Arcelor Chemicals
Biotavia Labs
Daewoong Chemical
Dipharma Francis
Erregierre
Grindeks
ICE
Mitsubishi Tanabe
Pharma Zell
Suzhou Tianlu
Zhangshanbelling
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Dosage Form
o Market Snippet, By Mode of Extraction
o Market Snippet, By Application
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Clinical Studies
o Epidemiology Analysis
o PORTER'S Five Forces
4. Global Ursodeoxycholic Acid Market, By Dosage Form, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Solid
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Liquid
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Ursodeoxycholic Acid Market, By Mode of Extraction, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Synthetic
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Biological
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Ursodeoxycholic Acid Market, By Application, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Gallstones
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Cystic Fibrosis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Liver Cirrhosis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
7. Global Ursodeoxycholic Acid Market, By Region, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Mode of Extraction, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Mode of Extraction, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Mode of Extraction, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Mode of Extraction, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Mode of Extraction, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Mode of Extraction, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Abil Chempharma
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Arcelor Chemicals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Biotavia Labs
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Daewoong Chemical
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Dipharma Francis
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Erregierre
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Grindeks
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o ICE
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Mitsubishi Tanabe
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Pharma Zell
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Suzhou Tianlu
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Zhangshanbelling
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 22 market data tables and 25 figures on "Ursodeoxycholic Acid Market" - Global forecast to 2026".
Request Discount 
Inquire Before Buy
